Портал психологических изданий PsyJournals.ru
Каталог изданий 107Рубрики 53Авторы 8884Новости 1776Ключевые слова 5095 Правила публикацииВебинарыRSS RSS

РИНЦ

Рейтинг Science Index РИНЦ 2019

30 место — направление «Психология»

0,404 — показатель журнала в рейтинге SCIENCE INDEX

1,000 — двухлетний импакт-фактор

CrossRef

Аутизм и нарушения развития

Издатель: Московский государственный психолого-педагогический университет

ISSN (печатная версия): 1994-1617

ISSN (online): 2413-4317

DOI: https://doi.org/10.17759/autdd

Лицензия: CC BY-NC 4.0

Издается с 2003 года

Периодичность: 4 номера в год

Язык журнала: Русский, английский

Доступ к электронным архивам: открытый

 

Биохимические аномалии при аутизме 133

Бокша И.С.
доктор биологических наук, главный научный сотрудник, ФГБНУ «Научный центр психического здоровья», Москва, Россия

Ссылка для цитирования

Благодарности

Автор выражает глубокую признательность д-ру Елизабете Мукаетовой-Ладинска (Университет Ньюкасла, Великобритания), д-ру Т.П. Клюшник (НЦПЗ РАМН), и д-ру В.В. Монахову (НЦПЗ РАМН) за ценные замечания и обсуждения.

Фрагмент статьи

Настоящий обзор посвящен биохимическим аномалиям, встречающимся при расстройствах, классифицируемых в психиатрии (ICD-10 раздел F84.-) как детский аутизм – «первазивные расстройства развития нервной системы, ПРР»,  (neurodevelopmental disorder). В этот раздел включены: аутистическое расстройство (или синдром Каннера, аутистическое расстройство, психоз раннего детского возраста) – F84.0; атипичный детский аутизм – F84.1; синдром Ретта – F84.2; другие дезинтегративные расстройства детского возраста – F84.3, гиперактивные расстройства, сочетающиеся с умственной отсталостью и стереотипными движениями – F84.4; а также синдром Аспергера – F84.5 (ICD-10, редакция 2005 г.).  

Литература
  1. www. autism. org ; www. pages. prodigy. net /unohu /endorphins.htm #Autism (1995)(Internet - ресурс)
  2. The Autism Chromosome Rearrangement Database (Internet - ресурс)
  3. Aldred S., Moore K.M., Fitzgerald M., Waring R.H. Plasma amino acid levels in chil­dren with autism and their families. (2003) J. Autism Dev. Disord. 33(1):93-97.
  4. www.autisme.ocisi.net;  www.autism-pdd.net/autism.htm;  www. autism-society. org; www.autism.org (Internet - ресурсы)
  5. Baghdadli A., Gonnier V., Aussilloux, C. Review of psychopharmacological treat­
    ments in adolescents and adults with autistic disorders. (2002) Encephale 28(3): 248-254.
  6. Bah J., Quach H., Ebstein R.P., Segman R.H., Melke J., Jamain S., Rietschel M.,
    Modai I., Kanas K., Karni O., Lerer B., Gourion D., Krebs M.O., Etain B., Schurhoff F., Szoke A., Leboyer M., Bourgeron T. Maternal transmission disequilibrium of the glut a-
    mate receptor GRIK2 in schizophrenia. (2004) Neuroreport 15(12) :1987-1991.
  7. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M: Autism as a strongly genetic disorder: evidence from a British twin study. (1995) Psychol. Med. 25:63-77.
  8. Bartlett Ch.W., Goedken Rh., Vieland V.J. Effects of updating linkage evidence
    across subsets of data: Reanalysis of the autism genetiv resource exchange data set. (2005) Am. J. Hum. Genet. 76:688-695.
  9. Bear M. F., Huber K. M., Warren S. T. The mGluR theory of fragile X mental retardation. (2004) Trends Neurosci. 27(7):370-377.
  10. Belsito K.M., Law P. A., Kirk K.S., Landa R.J., Zimmerman A.W. Lamotrigine thera­py for autistic disorder: a randomized, double-blind, placebo-controlled trial. (2001) J. Autism Dev. Disord. 31(2):175-181.
  11. Berry-Kravis E., Potanos K. Psychopharmacology in fragile X syndrome—-present and future. (2004) Ment. Retard. Dev. Disabil. Res. Rev. 10(1):42-48.
  12. Betancur C., Corbex M., Spielewoy C., Philippe A., Laplanche J.L., Launay J.M.,
    Gillberg C., Mouren-Simeoni M.C., Hamon M., Giros B., Nosten-Bertrand M., Leboyer M. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disor­der. (2002) Mol. Psychiatry 7(1):67-71.
  13. Blatt G.J., Fitzgerald C.M., Guptill J.T., Booker A. B., Kemper T.L., Bauman M.L.
    Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. (2001) J. Autism Dev. Disord. 31(6):537-43.
  14. Blaxill MF. What's going on? The question of time trends in autism. (2004) Public Health Rep., 119(6):536-551.
  15. Brasic J. R. March 16, 2005 www.emedicine.com/ped/topic180.htm Pervasive
    Developmental Disorder: Autism (Eds): Berkowitz C. D., MD, et al. (Internet - ресурс)
  16. Carlsson M.L. Hypothesis: is infantile autism a hypoglutamatergic disorder? Rele­vance of glutamate-serotonin interactions for pharmacotherapy. (1998) J. Neural Transm. 105:525-535.
  17. Chandana S.R., Behen M.E., Juhasz C., Muzik O., Rothermel R.D., Mangner T.J.,
    Chakraborty P.K., Chugani H.T., Chugani D.C. Significance of abnormalities in deve­lopmental trajectory and asymmetry of cortical serotonin synthesis in autism. (2005) Int. J. Dev. Neurosci. 23(2-3):171-182.
  18. Chauhan A., Chauhan V., Brown W. T., Cohen I. Oxidative stress in autism: Incre­ased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins (2004) Life Sci. 75 (21): 2539-2549.
  19. Chih B., Engelman H., Scheiffele P. Control of excitatory and inhibitory synapse
    formation by neuroligins. (2005) Science 307(5713): 1324-1328. E-pub 2005 Jan 27.
  20. Chugani DC. Serotonin in autism and pediatric epilepsies. (2004) Ment. Retard. Dev. Disabil. Res. Rev. 10(2): 112-116.
  21. Cook E.H. Jr, Arora R.C., Anderson G.M., Berry-Kravis E.M., Yan S.Y., Yeoh H.C.,
    Sklena P.J., Charak D.A., Leventhal B.L. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. (1993) Life Sci. 52(25): 2005-2015.
  22. Cook E.H., Leventhal B.L. The serotonin system in autism. (1996) Curr. Opin.
    Pediatr. 8(4):348-354.
  23. Cuccaro M.L., Wright H.H., Abramson R.K., Marstellar F.A., Valentine J. Whole-
    blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. (1993) J. Neuropsychiatry Clin. Neurosci. 5: 94-101.
  24. Dhossche D.M., Stanfill S. Could ECT be effective in autism? (2004) Med.
    Hypotheses 63(3) :371-376.
  25. Farber N.B., Newcomer J.W., Olney J.W. The glutamate synapse in neuro-
    psychiatric disorders. (1998) In: Ottersen O.P., Langmoen I.A., Gjerstad L. (Eds.): Progress in brain research. 116:421 -437.
  26. Fatemi S.H., Halt A. R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. (2002) Biol. Psychiatry 52(8):805-810.
  27. Freedman D.X., Belendiuk K., Belendiuk G.W., Crayton J.W. Blood tryptophan
    metabolism in chronic schizophrenics. (1981) Arch. Gen. Psychiatry 38(6):655-659.
  28. Gillberg Ch. Infantile autism: diagnosis and treatment. (1990) Acta Psychiatr.
    Scand. 81(3):209-215.
  29. Gillberg Ch., Coleman M. (1992) The Biology of the Autistic Syndromes - 2nd Edit­ion. Mac Keith Press, Oxford: Blackwell Sci. Publ. Ltd. N. Y.: Cambridge Univ. Press.
  30. Gillberg Ch., Coleman M. The biology of the autistic syndromes, 3rd ed., Ser.:
    Clinics in developmental medicine (Mac Keith Press), 2000.
  31. Grether J., Croen L., Theis C., Blaxill M., Haley B., Holmes A. Baby hair, mercury
    toxicity and autism. (2004) Int. J. Toxicol. 23(4):275-276.
  32. Holmes A.S., Blaxill M.F., Haley B.E. Reduced levels of mercury in first baby hair­
    cuts of autistic children. (2003) Int. J. Toxicol. 22(4) :277-285.
  33. Hussman J.P. Suppressed GABAergic inhibition as a common factor in suspected
    etiologies of autism. (2001) J. Autism Dev. Disorders 31(2):247-248(2) www.hussman. org/research/jaddgaba.pdf
  34. Jamain S., Betancur C., Quach H., Philippe A., Fellous M., Giros B., Gil l berg C.,
    Leboyer M., Bourgeron T. Linkage and association of the glutamate receptor 6 gene with autism. Paris Autism Research International Sibpair (PARIS) Study. (2002) Mol. Psychiatry 7(3):302-310.
  35. James Robert Brasic, Pervasive Developmental Disorder: Autism. March 16, 2005 www. emedicine. com/ped/topic 180. htm (Internet - ресурс)
  36. Jiang YH, Sahoo T, Michaelis RC, Bercovich D, Bressler J, Kashork CD, Liu Q, Shaf­fer LG, Schroer RJ, Stockton DW, Spielman RS, Stevenson RE, Beaudet AL. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. (2004) Am. J. Med. Genet. 131A(1):1-10.
  37. Junaid M.A., Kowal D., Barua M., Pullarkat P.S., Sklower Brooks S, Pullarkat R.K.
    Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. (2004) Am. J. Med. Genet. 131A(1):11-17.
  38. Kaufman S., Holtzman N., Milstein S., Butler I. J., Krumholz A. Phenylketonuria due to deficiency of dihydropteridine reductase (1975) New England J. Med., 293, 785-790.
  39. King B.H., Wright D.M., Handen B.L., Sikich L., Zimmerman A. W., McMahon W.,
    Cantwell E., Davanzo P.A., Dourish C.T, Dykens E.M., Hooper S.R., Jaselskis C.A., Leventhal B.L., Levitt J., Lord С, Lubetsky M.J., Myers S.M., Ozonoff S., Shah B.G., Snape M., Shernoff E.W, Williamson K., Cook E.H. Jr. Double-blind, placebo-control­ led study of amantadine hydrochloride in the treatment of children with autistic disor­der. (2001) J. Am. Acad. Child Adolesc. Psychiatry 40(6):658-665.
  40. Kotsopoulos S., Kutty K.M. Histidinemia and infantile autism. (1979) J. Autism
    Dev. Disord. 9(1):55-60.
  41. KЪves K., Kausz M., Reser D., IllyОs G., TakЗcs J., Heinzlmann A., Gyenge E.,
    HorvЗth K. Secretin and autism: a basic morphological study about the distribution of secretin in the nervous system. (2004) Regulatory Peptides 123 (1-3), 209-216; 6th International Symposium on VIP, PACAP and Related Peptrides
  42. Krystal J.H., D'Souza D.C., Petrakis I.L., Belger A, Berman R.M., Charney D.S.,
    Abi-Saab W., Madonick S. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. (1999) Harv. Rev. Psychiatry 7(3): 125-143.
  43. Lambe E.K., Picciotto M.R., Aghajanian G.K. Nicotine induces glutamate release
    from thalamocortical terminals in prefrontal cortex. (2003) Neuropsychopharmacology, 28(2):216-225.
  44. Laszlo A., Horvath E., Eck E., Fekete M. Serum serotonin, lactase and pyruvate lev­els in infantile autistic children. (1994) Clin. Chim. Acta 229: 205-207.
  45. Launay J.M., Bursztejn C., Ferrari P., Dreux C., Braconnier A., Zarifian E., Lancrenon S., Fermanian J. Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. (1987) J. Autism Dev. Disord. 17(3):333-347.
  46. Launay J.M., Ferrari P., Haimart M., Bursztejn C., Tabuteau F., Braconnier A.,
    Pasques-Bondoux D., Luong C., Dreux C. Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. (1988) Neuropsychobiology 20 (1):1-11.
  47. Leventhal B.L., Cook E.H. Jr, Morford M., Ravitz A., Freedman D.X. Relationships of whole blood serotonin and plasma norepinephrine within families. (1990) J. Autism Dev. Disord. 20(4):499-511.
  48. Marek G.J. A novel approach to the identification of psychiatric drugs: serotonin-glutamate interactions in the prefrontal cortex. (2000) CNS Drug Rev. 6:206-218.
  49. Martin-Ruiz C.M., Lee M., Perry R.H., Baumann M., Court J.A., Perry E.K. Molecu­
    lar analysis of nicotinic receptor expression in autism. (2004) Brain Res. Mol. Brain Res. 123(1-2):81-90.
  50. McCauley J.L., Olson L.M., Delahanty R., Am in T., Nurmi E.L., Organ E.L., Jacobs M.M., Folstein S.E., Haines J.L., Sutcliffe J.S. A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism. (2004) Am. J. Med. Genet. 131B(1):51-59.
  51. McCracken J.T., McGough J., Shah B. McCracken J.T., McGough J., Shah B.,
    Cronin P., Hong D., Aman M.G., Arnold L.E., Lindsay R., Nash P., Hollway J., McDougle C.J., Posey D., Swiezy N., Kohn A., Scahill L., Martin A., Koenig K., Volkmar F., Carroll D., Lancor A., Tierney E., Ghuman J., Gonzalez N.M., Grados M., Vitiello B., Ritz L., Davies M., Robinson J., McMahon D. Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral prob­lems. (2002) N. Engl. J. Med. 347(5):314-321.
  52. McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., Price L.H. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. (1996) Arch. Gen. Psychiatry 53:1001-1008.
  53. McDougle C.J., Holmes J.P., Carlson D.C., Pelton G.H., Cohen D.J., Price L.H. A
    double-blind placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. (1998) Arch. Gen. Psychiatry 55:633-641.
  54. McDougle C.J., Kresch L.E., Posey D. J. Repetitive thoughts and behavior in perva­sive developmental disorders: treatment with serotonin reuptake inhibitors. (2000) J. Autism Dev. Disord. 30:427-435.
  55. McDougle Ch.J., Posey D. (2002) Genetics of childhood disorders: XLIV. autism,
    part 3: psychopharmacology of autism. J.Am.Acad.Child Adolesc. Psychiatry 41(11):1380-1383.
  56. Minzer K., Lee O., Hong J.J., Singer H.S. Increased prefrontal D2 protein in
    Tourette syndrome: a postmortem analysis of frontal cortex and striatum. (2004) J. Neurol. Sci. 219(1-2):55-61.
  57. Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L. Plasma excitatory amino acids in autism. (1996) Invest. Clin. 37(2): 113-128.
  58. Mulder E.J., Anderson G.M., Kema I.P., Brugman A.M., Ketelaars C.E., de Bildt A., van Lang N.D., den Boer J.A., Minderaa R.B. Serotonin transporter intron 2 poly­ morphism associated with rigid-compulsive behaviors in Dutch individuals with perva­sive developmental disorder. (2005) Am. J. Med. Genet. B. Neuropsychiatr. Genet., 133(1):93-96.
  59. Nilsson M., Carlsson A., Markinhuhta K.R., Sonesson C., Pettersson F., Gullme M., Carlsson M.L. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. (2004) Prog. Neuropsychopharmacol. Biol. Psychiatry 28(4):677-685.
  60. Nyhan W.L., James J.A., Teberg A.J., Sweetman L., Nelson L.G. A new disorder of purine metabolism with behavioral manifestations. (1969) J. Pediatr. 74(1):20-27.
  61. Peters S.U., Beaudet A.L., Madduri N., Bacino C.A. Autism in Angelman syndrome: implications for autism research. (2004) Clin. Genet. 66(6):530-536.
  62. Purcell A. E., Jeon O. H., Zimmerman A. W., Blue M. E., Pevsner J. Postmortem
    brain abnormalities of the glutamate neurotransmitter system in autism. (2001)
    Neurology 57:1618-1628.
  63. Rabionet R, Jaworski JM, Ashley-Koch AE, Martin ER, Sutcliffe JS, Haines JL,
    Delong GR, Abramson RK, Wright HH, Cuccaro ML, Gilbert JR, Pericak-Vance MA.
    Analysis of the autism chromosome 2 linkage region: GAD 1 and other candidate genes. (2004) Neurosci. Lett. 372(3):209-214.
  64. Ramoz N, Reichert JG, Smith CJ, Silverman JM, Bespalova IN, Davis KL, Buxbaum JD. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. (2004) Am. J. Psychiatry 161(4):662-669.
  65. Rutter M., Bartak L. Causes of infantile autism: some considerations from recent research. (1971) J. Autism Child Schizophrenia 1(1):20-32.
  66. Sandman C.A., Barron J.L., Chicz-DeMet A., DeMet E.M. Brief report: plasma
    beta-endorphin and cortisol levels in autistic patients (1991) J. Autism Dev. Disorders 21: 83-87.
  67. Santangelo SL, Tsatsanis K. What is Known About Autism : Genes, Brain, and Beha­vior. (2005) Am. J. Pharmacogenomics 5(2):71 -92.
  68. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in
    nonneuronal cells triggers presynaptic development in contacting axons. (2000) Cell 101(6) :657-669.
  69. Sengupta N., Bedford H., Elliman D., Booy R. Does the MMR triple vaccine cause
    autism? (2004) Evidence-Based Healthcare and Public Health 8(5): 239-245.
  70. Serajee F.J., Zhong H., Nabi R., Mahbubul Huq A. H. M. The metabotropic gluta-
    mate receptor 8 gene at 7q31: partial duplication and possible association with
    autism.        (2003)        J.        Med.        Genet.        40:       40:e42(http://www.jmed-genet.com/cgi/content/full/40/4/e42)
  71. Shuang M, Liu J, Jia MX, Yang JZ, Wu SP, Gong XH, Ling YS, Ruan Y, Yang XL,
    Zhang D. Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios. (2004) Am. J. Med. Genet. 131B(1):48-50.
  72. Singh V.K., Singh A., Warren R.J. Hyperserotoninemia and serotonin receptor anti­bodies in children with autism but not mental retardation. (1997) Biol. Psychiatry 41: 753-755.
  73. Sporn AL, Addington AM, Gogtay N, Ordonez AE, Gornick M, Clasen L, Greenstein D, Tossell JW, Gochman P, Lenane M, Sharp WS, Straub RE, Rapoport JL. Pervasive developmental disorder and childhood-onset schizophrenia: comorbid disorder or a phenotypic variant of a very early onset illness? (2004) Biol. Psychiatry 55(10) :989-994.
  74. Stone R.L., Aimi J., Barshop B.A., Jaeken J., Van den Berghe G., Zalkin H., Dixon J.E. A mutation in adenylosuccinate lyase associated with mental retardation and auti­stic features. (1992) Nat. Genet. 1(1):59-63.
  75. Stubbs G., Litt M., Lis E., Jackson R., Voth W., Lindberg A., Litt R. Adenosine
    deaminase activity decreased in autism. (1982) J. Am. Acad. Child Psychiatry
  76. Torres A. R. Hypothesis. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? (2003) BMC Pediatrics 3:9.
  77. utexas.edu/research/asrec/synapse.html
  78. Van de Water J., Ashwood P. Is autism an autoimmune disease? 2004 Auto immu­nity Reviews, V3, No7-8, 601 -603 From the 4th International Congress of Autoimmunity Copyright 2004 Published by Elsevier B. V
  79. Van den Berghe G., Vincent M.F., Jaeken J. Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. (1997) J. Inherit. Metab. Dis. 20(2): 193-202.
  80. Waage-Baudet H., Lauder J.M., Dehart D.B., Kluckman K., Hiller S., Tint G.S.,
    Sulik K.K. Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism. (2003) Int. J. Dev. Neurosci. 21(8):451-459.
  81. Weizman R., Gil-Ad I., Dick J., Tyano S., Szekely G., Laron Z. Low plasma immuno-reactive beta-endorphin. (1988) J. American Ac. Child Adolescent Psychiatry 27: 430-433.
  82. Weizman R., Weizman A., Tyano S., Szekely B.A., Sarne Y.H. Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects (1984) Psychopharmacology 82: 363-370.
  83. Welch M.G., Keune J.D., Welch-Horan T.B., Anwar N., Anwar M., Ludwig R.J.,
    Ruggiero D.A. Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism. (2004) Cell Mol. Neurobiol. 24(2):219-241.
  84. Westall F.C., Root-Bernstein R.S. Suggested connection between autism, seroto­nin, and myelin basic protein. (1983) Am. J. Psychiatry 140(9): 1260-1261.
  85. www.dimdi.de/de/klassi/diagnosen/icd10/htmlgm2005) (Internet - ресурс)
  86. Yuwiler A., Shih J.C., Chen C.H. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. (1992) J. Aut. Dev. Dis. 22 : 35-45.
  87. Zoroglu S.S., Armutcu F., Ozen S., Gurel A., Sivasli E., Yetkin O., Meram I. Incre­
    ased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. (2004) Eur. Arch. Psychiatry Clin. Neurosci. 254(3): 143-147.
  88. Башина В.М. Аутизм в детстве. "Медицина", Москва (1999).
  89. Бокша И. С. Взаимосвязь нейронов и глиальных клеток через метаболизм
    глутамата в мозге здоровых людей и больных психическими заболеваниями.
    (2004) Биохимия 69(7):869-886.
  90. Клюшник Т.П., Козловская Г.В., Калинина М.А., Щербакова И.В. Изд-во
    Правительства Москвы и Департамента Здравоохранения, Москва, 2004
Статьи по теме
 
О проекте PsyJournals.ru

© 2007–2020 Портал психологических изданий PsyJournals.ru  Все права защищены

Свидетельство регистрации СМИ Эл № ФС77-66447 от 14 июля 2016 г.

Издатель: ФГБОУ ВО МГППУ

Creative Commons License Репозиторий открытого доступа     Рейтинг репозиториев Webometrics

Яндекс.Метрика